\
&
Contact us
\
&
Contact us
Starts in 4 hours from now
LocationBrussels
ProgrammesThe Innovative Health Initaitive (IHI) partnership will hold a brokerage event with the aim to provide stakeholders interested in IHI’s next single-stage call for proposals (Call 12) with the opportunity to network face-to-face and start forming consortia. IHI Call 12 is scheduled to be launched in early 2026.
The event will include pitching sessions and poster sessions to give research organisations, patient groups, and companies a chance to showcase their project ideas. IHI has made available an online networking platform for (potential) applicants to share ideas and network also after the event.
Registration is now open for this event. More information on the event on the IHI dedicated event page.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
